Thomas Jefferson UniversityJefferson Medical College

Main menu:

Research & Publications

Recent Publications

Dapagliflozin is effective as add-on therapy to sitagliptin with or withoutmetformin: A 24-Week, multicenter, randomized, double-blind, placebo-controlled study

SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.

Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer?

Ramadan: Type 2 diabetes and risk of hypoglycaemia

Visual vignette

Collaboration designed to increase translation of diabetes research outcomes into clinical practice

Denosumab: Do we need another of the same?

Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor Dapagliflozin

Subclinical hyperthyroidism: Current concepts and scintigraphic imaging

Exenatide once weekly in type 2 diabetes mellitus

Sodium Glucose Cotransporter 2 Inhibitors

Management of diabetes mellitus in the elderly

46, XX SRY-positive male syndrome presenting with primary hypogonadism in the setting of scleroderma

Advantages of extended-release metformin in patients with type 2 diabetes mellitus

Skin manifestations of hormone-secreting tumors

The importance of reducing hyperglycemia while preserving insulin secretion-the rationale for sodium-coupled glucose co-transporter 2 inhibition in diabetes

Visual vignette.

Editorial: Type 2 diabetes and HbA1c goal: Time for individualised therapy

Perioperative Management of Endocrine Disorders

A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS